Net Income (TTM) Chart

View Net Income (TTM) for URGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -97.64M
March 31, 2026 -133.22M
December 31, 2025 -153.49M
September 30, 2025 -164.64M
June 30, 2025 -154.97M
March 31, 2025 -138.43M
December 31, 2024 -126.87M
September 30, 2024 -115.38M
June 30, 2024 -113.58M
March 31, 2024 -104.32M
December 31, 2023 -102.24M
September 30, 2023 -104.48M
June 30, 2023 -108.43M
March 31, 2023 -110.98M
December 31, 2022 -109.16M
September 30, 2022 -109.37M
June 30, 2022 -113.75M
Date Value
March 31, 2022 -113.28M
December 31, 2021 -110.82M
September 30, 2021 -112.89M
June 30, 2021 -111.50M
March 31, 2021 -116.63M
December 31, 2020 -128.48M
September 30, 2020 -136.93M
June 30, 2020 -130.37M
March 31, 2020 -121.50M
December 31, 2019 -105.15M
September 30, 2019 -89.89M
June 30, 2019 -88.17M
March 31, 2019 -83.72M
December 31, 2018 -75.66M
September 30, 2018 -62.01M
June 30, 2018 -41.77M
March 31, 2018 -29.95M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Xencor, Inc. -163.32M
MeiraGTx Holdings Plc 78.93M
Insmed, Inc. -875.31M
Ironwood Pharmaceuticals, Inc. 129.87M
Viking Therapeutics, Inc. -534.80M